IN2010CH03577A - - Google Patents
Download PDFInfo
- Publication number
- IN2010CH03577A IN2010CH03577A IN3577CH2010A IN2010CH03577A IN 2010CH03577 A IN2010CH03577 A IN 2010CH03577A IN 3577CH2010 A IN3577CH2010 A IN 3577CH2010A IN 2010CH03577 A IN2010CH03577 A IN 2010CH03577A
- Authority
- IN
- India
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3577CH2010 IN2010CH03577A (en) | 2010-11-26 | 2011-11-11 | |
| US13/989,602 US8703788B2 (en) | 2010-11-26 | 2011-11-11 | Polymorph of nilotinib hydrochloride |
| EP11843202.0A EP2648519A4 (en) | 2010-11-26 | 2011-11-11 | Novel polymorph of nilotinib hydrochloride |
| PCT/IN2011/000779 WO2012070062A2 (en) | 2010-11-26 | 2011-11-11 | Novel polymorph of nilotinib hydrochloride |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3577CH2010 IN2010CH03577A (en) | 2010-11-26 | 2011-11-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2010CH03577A true IN2010CH03577A (en) | 2012-07-20 |
Family
ID=46146222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3577CH2010 IN2010CH03577A (en) | 2010-11-26 | 2011-11-11 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US8703788B2 (en) |
| EP (1) | EP2648519A4 (en) |
| IN (1) | IN2010CH03577A (en) |
| WO (1) | WO2012070062A2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9376419B2 (en) | 2012-10-15 | 2016-06-28 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2648519A4 (en) * | 2010-11-26 | 2014-04-30 | Hetero Research Foundation | Novel polymorph of nilotinib hydrochloride |
| EA201592032A1 (en) | 2013-04-24 | 2016-04-29 | Др. Реддис Лабораторис Лимитед | POLYMORPHIC FORMS OF NILOTINIB HYDROCHLORIDE |
| WO2015092624A1 (en) | 2013-12-16 | 2015-06-25 | Ranbaxy Laboratories Limited | Nilotinib mono-oxalate and its crystalline form |
| EP3177610A4 (en) | 2014-08-08 | 2018-01-10 | Dr. Reddy's Laboratories Ltd. | Process for the preparation of polymorphic forms of nilotinib |
| PT3189045T (en) * | 2014-08-11 | 2022-03-17 | Sun Pharmaceutical Ind Ltd | Novel salts of nilotinib and polymorphs thereof |
| US10016423B2 (en) | 2014-10-16 | 2018-07-10 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
| EP3404025B1 (en) * | 2017-05-16 | 2019-12-04 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of pure nilotinib and its salt |
| CN107188887A (en) * | 2017-06-15 | 2017-09-22 | 苏州立新制药有限公司 | A kind of AMN107 oxidative degradation impurity and preparation method thereof |
| CZ2017821A3 (en) | 2017-12-20 | 2019-07-03 | Zentiva, K.S. | Dosing of crystalline nilotinib |
| EP3806858A4 (en) | 2018-06-15 | 2022-03-09 | Handa Pharmaceuticals, Inc. | Kinase inhibitor salts and compositions thereof |
| EP3877379A4 (en) * | 2018-11-05 | 2022-08-31 | Laurus Labs Limited | Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4216318A (en) * | 1975-12-29 | 1980-08-05 | Smith Kline & French Laboratories Limited | Heterocyclic alkyl 4-pyrimidones |
| JP2657760B2 (en) * | 1992-07-15 | 1997-09-24 | 小野薬品工業株式会社 | 4-aminoquinazoline derivatives and pharmaceuticals containing them |
| CA2450555A1 (en) * | 2001-06-25 | 2003-01-03 | Merck & Co., Inc. | (pyrimidyl)(phenyl)substituted fused heteroaryl p38 inhibiting and pkg kinase inhibiting compounds |
| GB0215676D0 (en) * | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| GB2398565A (en) * | 2003-02-18 | 2004-08-25 | Cipla Ltd | Imatinib preparation and salts |
| GT200600315A (en) * | 2005-07-20 | 2007-03-19 | CRYSTAL FORMS OF 4-METHYL-N- [3- (4-METHYL-IMIDAZOL-1-ILO) -5-TRIFLUOROMETILO-PHENYL] -3- (4-PYRIDINA-3-ILO-PIRIMIDINA-2-ILOAMINO) -BENZAMIDA | |
| GT200600316A (en) * | 2005-07-20 | 2007-04-02 | SALTS OF 4-METHYL-N- (3- (4-METHYL-IMIDAZOL-1-ILO) -5-TRIFLUOROMETILO-PHENYL) -3- (4-PIRIDINA-3-ILO-PIRIMIDINA-2-ILOAMINO) - BENZAMIDA. | |
| US20100016590A1 (en) * | 2008-07-17 | 2010-01-21 | Teva Pharmaceutical Industries Ltd. | Nilotinib intermediates and preparation thereof |
| PL2262793T3 (en) * | 2008-11-05 | 2013-01-31 | Teva Pharma | Nilotinib hci crystalline forms |
| WO2011086541A1 (en) * | 2010-01-15 | 2011-07-21 | Generics [Uk] Limited | Novel polymorph of nilotinib monohydrochloride monohydrate |
| PL2571863T3 (en) * | 2010-06-21 | 2016-03-31 | Teva Pharma | Nilotinib salts and crystalline forms thereof |
| CN102453024B (en) * | 2010-10-27 | 2014-09-03 | 浙江九洲药业股份有限公司 | Nilotinib hydrochloride crystalline form and preparation method thereof |
| EP2648519A4 (en) * | 2010-11-26 | 2014-04-30 | Hetero Research Foundation | Novel polymorph of nilotinib hydrochloride |
-
2011
- 2011-11-11 EP EP11843202.0A patent/EP2648519A4/en not_active Withdrawn
- 2011-11-11 WO PCT/IN2011/000779 patent/WO2012070062A2/en active Application Filing
- 2011-11-11 US US13/989,602 patent/US8703788B2/en not_active Expired - Fee Related
- 2011-11-11 IN IN3577CH2010 patent/IN2010CH03577A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9376419B2 (en) | 2012-10-15 | 2016-06-28 | Apotex Inc. | Solid forms of nilotinib hydrochloride |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012070062A3 (en) | 2012-06-21 |
| US20130245052A1 (en) | 2013-09-19 |
| WO2012070062A2 (en) | 2012-05-31 |
| EP2648519A2 (en) | 2013-10-16 |
| EP2648519A4 (en) | 2014-04-30 |
| US8703788B2 (en) | 2014-04-22 |